Mario Gabelli Bausch Health Companies Inc. Transaction History
Gamco Investors, Inc. Et Al
- $8.37 Billion
- Q1 2025
A detailed history of Mario Gabelli (Gamco Investors, Inc. Et Al) transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Gamco Investors, Inc. Et Al holds 1,043,441 shares of BHC stock, worth $7.3 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
1,043,441
Previous 1,075,141
2.95%
Holding current value
$7.3 Million
Previous $8.67 Million
22.09%
% of portfolio
0.08%
Previous 0.1%
Shares
26 transactions
Others Institutions Holding BHC
# of Institutions
266Shares Held
246MCall Options Held
3.66MPut Options Held
11.3M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$243 Million3.02% of portfolio
-
Goldentree Asset Management LP New York, NY30.3MShares$212 Million17.26% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$185 Million9.81% of portfolio
-
Nomura Holdings Inc Tokyo, M023.4MShares$164 Million0.32% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$91 Million0.19% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.53B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...